For example, CTL induction against DEPDC1 and MPHOSPH1 has been previously observed in patients with bladder cancer in response to a cancer vaccine comprising two peptides administered weekly for 12 weeks [24, 25]. The gene discussed is DEPDC1; the disease is urinary bladder cancer.